Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
- Conditions
- ShockCritical Illness
- Registration Number
- NCT07020637
- Lead Sponsor
- University of Nevada, Las Vegas
- Brief Summary
This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.
- Detailed Description
In this prospective observational study, patients presenting with clinical signs of shock will be enrolled after obtaining informed consent. Stroke volume (SV) will be measured using both transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring (Cheetah NICOM). SV will be recorded before and after passive leg raising (PLR) to evaluate the correlation between the two methods in terms of absolute values and directional changes (increase or decrease). No therapeutic intervention will be performed as part of the study; all clinical decisions will remain under the discretion of the treating medical team.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Not provided
- Pregnancy
- Known severe aortic valve disease or dynamic left ventricular outflow tract obstruction
- Morbid obesity (BMI > 40) that precludes accurate echocardiographic imaging Presence of cardiac arrhythmias (e.g., atrial fibrillation with rapid ventricular response) affecting stroke volume measurements
- Implanted cardiac assist devices (e.g., LVAD, pacemaker dependency)
- Imminent death or decision for comfort care only
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation Between Stroke Volume Measurements by Echocardiography and Bioreactance Monitoring Within 1 hour of enrollment Pearson correlation coefficient between stroke volume measurements obtained using transthoracic echocardiography and those obtained using bioreactance-based monitoring (Cheetah NICOM) in response to passive leg raising.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Medical Center Southern Nevada
🇺🇸Las Vegas, Nevada, United States
University Medical Center Southern Nevada🇺🇸Las Vegas, Nevada, United StatesMutsumi J Kioka, Medical DoctorContact7026712345mutsumi.kioka@unlv.edu